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Recent advances in rickettsial diseases 
(ESCMID European Study Group on 
Bartonella, Coxiella, Ehdichia and Rickettsia) 
New Bartonelh Infections 
D. Raoult. Unit6 des Ricktttsies, Uniuersiti de la Miditmanke, UPRES 
A-CNRS 6020, ManeiZle, France 
Bartonella are small gram negative bacteria which have been isolated 
from humans and mammals. Human infections due to Bartonella 
species are being increasingly reported, and are now considered 
‘emerging’ dseases. Bartonella (formerly Rorhalimaea) quintana, his- 
torically associated with trench fever, is now being re-encountered, 
especdy among the homeless and alcoholics, manifesting as endo- 
carditis, trench fever, mediastitial lymph node enlargements and (in 
AIDS patients) bacillary angiomatosis. B. henselae is prevalent in do- 
mestic cats and several genotypes and serotypes exist. It causes cat 
scratch disease, bacillary angiomatosis and hepatic peliosis. B. eliza- 
bethae has been isolated h m  one case of endocarditis. 
Bartonella species have been shown to cause 3% of endocardi- 
tls in three series. Other BartoneZla species have been isolated from 
mammals (dogs, cats, rodents) but their role in human disease is 
currently unknown. 
The Emergence of Human Granulocytic 
Ehrlichiosis (HGE), an Old and New World 
Ti&-Borne Anthropozoonosis 
J.S. Dumler. Thejohns Hopkins Medical Institutions, Baltimore, MD, 
USA 
HGE was first recognized in Wisconsin and lMinnesota in 1990. 
Since then over 200 cases have been idended. Most patients present 
with an undifferentiated febrile illness with fever, malaise, myalgia, 
and headache often accompanied by leukopenia, thrombocytopenia, 
and elevated serum hepatic transaminase activities. Seroepidemio- 
logic studies indicate that most infections are mild. Symptomatic 
mfection responds well to doxycycline. Up to 7% of patients require 
intensive care and at least 4 have died. Serologic evidence of infec- 
tion in Europe is now well established, and at least one symptomatic 
infection in Europe has been documented. The causative agent is 
genetically, antigenically, and biologically closely rekted to the vet- 
erinary granulocytic EhrZichia species, E .  phagocytophila and E .  equi. 
These obligate intracellular bacteria are transmitted by Ixodes per- 
suhtus-complex ticks. The natural reservoirs in the eastern United 
States are s m a l l  mammals, especially white-footed mice, Peromyscus 
leucopur. The role of deer as reservoirs is not currently known. The 
btribution of the agent, the exact spectrum of disease, the c h -  
ical sequelae of co-transmitted infectious agents, the pathogenesis, 
and the mechanisms of host defense defects are unknown, but merit 
serious world-wide investigation. 
New and Classical Rickettsiae in Europe and the 
Former USSR 
M. Eremeeva. The N.E Gamaleya Research Institute of Epidemiology 
and Microbiology, Moscou: Russia 
Until recently only five species of spotted fever group (SFG) rick- 
ettsiae, Rickettsia wnorii, R. sibirica, R. akari, R. slovaca and R. hel- 
uetica, were known from spec& foci in Western Europe to the 
Primorye region of Russia. R. typhi, the agent of murine typhus 
is found dong the costar areas while R. prowazekii causes sporadic 
cases of recrudescent typhus. In the last two decades an unexplained 
increase of SFG disease outbreaks has enhanced interest in these 
etiological entities and their agents. The introduction of new tools 
combining molecular-biological protein and genetic approaches with 
classical microbiological and serological techniques has permitted 
more accurate dragnosis of rickettsial &seas= and idendcation of 
agents. Recent studies have resulted in expanding the known areas 
where classical SFG rickettsiae circulate; idendcation of two novel 
species and four new rickettsia biotypes in old foci or in newly dis- 
covered endemic areas; description of antigenic and genetic hetero- 
geneity of circulating R. conorii; and identification of new species of 
lxodid ticks harboring SFG rickettsiae. These findings raised a num- 
ber of questions concerning the epidemiology of rickettsial diseases. 
The phylogenetic information obtained from the data has generated 
new concepts about the taxonomy and evolution of these rickettsiae 
and their relationship to their acarian vectors. 
LS180 I Coxiella burnetti: Recent Advances 
J. Kazir. Institute of Preuentiue and Clinical Medinne, Bratislava, Slovak 
Republic 
CoxielIa burnetii belongs to obligate intracellular bacteria. U d k e  
other rickettsiae, C. Bumetii is thermophilic (resistant to thermal, 
physical and chemical shock), acidophilic (propagates in the harsh 
environment of the phagolysosomes of eukaryotic cells), under- 
goes phase variation (the change of properties upon passaging in 
different substrates) and sporogenic differentiation, and is transmit- 
ted to humans usually by the inhalation of contaminated aerosols. 
Though C. burnetii strains associated with acute or chronic form 
of human disease may differ in their plasmid content and size or 
lipopolysaccharide structure, for developing the chronic form of Q 
fever, host factors rather than propemes of the agent are responsible. 
Molecular biology approach and genetic studies can result not only 
in better understanding of the agent and its pathogenic potenaal, 
but also in improvement of Q fever diagnosis and immunoprophy- 
h i s .  
Antibiotics in the hospital setting: 
Surveillance, resistance, spectra and agent 
selection 
I S181 1 Evolving hospital epidemiology and 
antiinfective considerations 
H. Goossens. University Hospital UL4, Microbiology Department, 
Anhump, Belgium 
Objectives: To consider trends in hospital epidemiology and to 
evaluate the impact on antimicrobial considerations. 
Methods: The emergence of bacterial strains which are re- 
sistant to several compounds causes concern about their use in 
certain circumstances. Resistance in Gram-negative bacteria is 
principally associated with the production of hydrolysing enzymes. 
Resistance in Gram-positive bacteria, such as pneumococci and 
viridans streptococci, is due to alrentions in the PBPs. A new 
group of broad-spectrum parented cephalosporins, so-called 
“fourth-generation” cephalosporins, have been developed. Thu 
new class of 7-methoxyimino cephalosporins, which are zwitte- 
rions, include cefepime, cefpimme, cefdidin, etc. The activity of 
various compounds, includmg cefepime against more than 2000 
Gram-negative and Gram-positive blood isolates was evaluated in 
Belgian hospitals. 
Results: Cefepime showed comparable activity to cefotaxime and 
ceftriaxone against Gram-positive isolates, superior activity to cef- 
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tazidune against inducible Gram-negative isolates, and comparable 
activity to ceftazldime against Pseudomom aeruginosa. 
Conclusion: Fourth generation cephalosporins are highly potent 
agents, but continued surveillance is mandatory. 
(s182j Antimicrobial surveillance programmes 
J.E Acar. Fondation H6pital SaintJoseph, Paris, France 
Currently, prevalence rates for nosocomial infections range between 
5% and 17% of patients adrmtted to hospitals. The control of noso- 
comial infections has been well recognised as a major priority in the 
hospital setting. Components for controhg nosocomial infections 
in the hospital indude antibiotics, which hold a rather ambivalent 
position: empirically used, antibiotics may select for resistant bac- 
teria. It is important to target the micro-organism and hmit the 
spread of resistant bacteria. Antimicrobial surveillance programmes 
are unique tools to detect and idennfy dangerous micro-organisms 
and to optimise the use of empiric antibiotic theram. A variety 
of surveillance programmes have been developed. Enhancements in 
surveillance have been related to improved sampling, accurate ch i -  
cal information, quantitative methods ofsusceptibility testing, quality 
control measures in the laboratory, as well as interpretation of the re- 
sults. The database of detailed mformation can be analysed with the 
appropriate software. The results can them be compared to mforma- 
tion gathered ate other institutions, on regional, national and global 
bases. 
1 S183 I Informed decisions in an era of resistance 
A.E Ehrhardt. Centerfor Research in Anti-Infectives G. Biotechnoloa, 
Creighton University, Omaha, hJE, USA 
Antimicrobial resistance is increasing worldwide. Recent increases 
in p-lactam resistance amongst Gram-negative bacteria such as En- 
teroborter cloacae, Citrobacter freundii, and Pseudomom aemginosa have 
been linked to use and overuse of ater-generation cephalosporins. 
Further resistance emergence may be delayed or reduced through 
the use of newer agents, combination therapy and antibiotic cychg. 
In vim data suggest that the fourth-generation cephalosporins are 
generally more potent than, and select less resistance than previ- 
ous agents. I n i d  clinical data, though yet sparse, suggest that sub- 
stitution of these agents for their predecessors, particularly when 
in combination with aminoglycosides, results in lower resistance 
rates. W e  clinical trials, due to their design, have shown drugs 
such as cefepime to be at least comparable to the third-generation 
cephalosporins, superiority of the fourth-generation agents is in- 
dicated in selected cases of infection with Bush group 1 en- 
zyme-producing bacteria. This superiority is at least partially due 
to the low inducing potential for the group 1 enzymes, rapid per- 
meation characteristics and resistance to hydrolysis. Organisms like 
E. cloacae can become resistant to thxd-generation agents through 
a single mutational step, while two mutations are required for re- 
sistance to the fourth-generation drugs. Adoption of practices and 
agents that reduce the selection of resistance may extend the use- 
ful lives of our current drugs, and may also delay the onset of the 
“post-antibiotic era”. 
S184 \ Empiric Therapy: Algorithms for Success 
J. Carlet. F 
No abstract available. 
I S185 I Management strategies for infection in the 
J. Klastersky. Department Oflntemal Medicine, ImtitutJuZes Bordet, 
BmsseL, Belgium 
neutropenic patient 
Neutropenic patients are susceptible to severe and prolonged infec- 
tion. Empiric therapy to prevent it has traditionally been designed 
to cover Gram-negative rods, especially P amginosa, which were the 
most likely bacterial pathogens. Over the past two decades however, 
Gram-positive infections have progressively become a more common 
cause of sepsis in neutropenic patients, now accounting for 70% of 
infections. Adequate coverage against Gram-negative organisms re- 
mains nevertheless mandatory. It is performed usually with a combi- 
nation ofantibiotics but recently introduced antibiotics like cefepime 
and meropenem have been used successfully as a monotherapy These 
agents have an excellent antipseudomal activity, they are synergis- 
tic with aminoglycosides and, moreover, are effective against many 
streptococci and methicillin-sensitive staphylococci. Vancomycin or 
teicoplanin are only indicated in the presence of a resistant organism, 
most commonly Staph. cpidermidis. The addition of amphotericin B 
is indicated after 96 hours if the patient remains neutropenic and 
febrile, and the initial microbiological workup has been negative. 
This is especially the case in patients with severe neutropenia and/or 
a newly apparent c h c a l  site of infection. The suspicion of fun- 
gal infections should be even higher in neutropenic patients who 
are immunosuppressed, such as those with graft-versus-host dwease 
after allogeneic bone marrow transplantation. In those patients, cy- 
tomegalovirus and other vital infections should be looked for and 
treated early Colony stimulating factors can effectively shorten the 
duration of neutropenia and can be used as an adjunct to antibacte- 
rial and antifungal agents when neutropenia is severe and the control 
of dection is not optimal. 
Endothelium and microbial interactions 
(Joint Symposium with the Infectious 
Diseases Society of America) 
Endotoxin Influences Endothelial Barrier 
Function 
S.E. Goldblum. VA Maryland Health Care System, University o j  
Maryland School of Medicine, Balfimore, Maryland, USA 
Gram-negative septic processes can be complicated by vascular leak 
syndromes, including the adult respiratory &tress syndrome. The 
bacterial component responsible for much of the endothelial cell 
(EC) injury and dysfunction is the bacterial lipopolysaccharide 
(LPS). Although LPS induces numerous host medators of EC in- 
jury, evidence also exists for a direct role for LPS. LPS, in concert 
with the accessory molecules LPS-bindmg protein (LBP) and soluble 
CD14, directly interacts with the vascular EC to induce loss of bar- 
rier function through the paracellular pathway. The molecular basis 
for this LPS-EC interaction and the resultant EC response have not 
been defined. A specific binding site/receptor for LPS on the non 
CD14-bearing EC, although implied, has not been demonstrated. 
We now know that LPS induces tyrosine phosphorylation of a cy- 
toskeletal protein, p&, and that protein p s i n e  kmase inhibition 
protects against opening of the EC paracellular pathway in response 
to LPS. The phosphopsine-containing proteins in LPS-exposed 
EC can be immunolocalized in part, to the intercellular boundaries. 
The LPS-induced endothelial barrier dysfunction also appean to 
be mediated through actin reorganization. LPS induces EC actin de- 
polymerization and prior F-actin stabilization with phallicidin pm- 
